Regeneron Pharmaceuticals Aktie

Kaufen
Verkaufen
710,40 EUR +6,60 EUR +0,94 %
744,25 USD +1,48 USD +0,20 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 77,58 Mrd. EUR

KGV 25,26 Div. Rendite 0,00%

WKN 881535

ISIN US75886F1075

Symbol REGN


Regeneron Pharmaceuticals Aktie Analyse

27.03.15 Regeneron Pharmaceuticals Buy Argus Research Company
20.03.15 Regeneron Pharmaceuticals Buy Chardan Capital Markets
19.02.15 Regeneron Pharmaceuticals Neutral ROTH Capital Partners, LLC
17.02.15 Regeneron Pharmaceuticals Buy Argus Research Company
11.02.15 Regeneron Pharmaceuticals Neutral UBS AG
11.02.15 Regeneron Pharmaceuticals Outperform RBC Capital Markets
02.02.15 Regeneron Pharmaceuticals Outperform RBC Capital Markets
20.11.14 Regeneron Pharmaceuticals Buy Brean Capital
19.11.14 Regeneron Pharmaceuticals Buy ROTH Capital Partners, LLC
11.11.14 Regeneron Pharmaceuticals Buy Argus Research Company
05.11.14 Regeneron Pharmaceuticals Outperform RBC Capital Markets
24.10.14 Regeneron Pharmaceuticals Buy Canaccord Adams
20.11.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
29.08.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
22.08.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
27.07.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
25.07.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
23.07.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
10.05.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
24.04.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
23.03.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
14.02.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
18.01.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
11.01.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
10.01.12 Regeneron Pharmaceuticals outperform Robert W. Baird & Co. Incorporated
21.11.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
15.11.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
14.10.11 Regeneron Pharmaceuticals neutral Citigroup Corp.
06.10.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
22.09.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
29.08.11 Regeneron Pharmaceuticals hold Citigroup Corp.
23.08.11 Regeneron Pharmaceuticals buy Citigroup Corp.
18.08.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
12.08.11 Regeneron Pharmaceuticals buy Citigroup Corp.
28.07.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
22.07.11 Regeneron Pharmaceuticals sector perform RBC Capital Markets
21.07.11 Regeneron Pharmaceuticals sector perform RBC Capital Markets
16.06.11 Regeneron Pharmaceuticals buy Citigroup Corp.
09.05.11 Regeneron Pharmaceuticals buy Needham & Company, LLC
03.05.11 Regeneron Pharmaceuticals overweight Barclays Capital
02.05.11 Regeneron Pharmaceuticals overweight Barclays Capital
29.04.11 Regeneron Pharmaceuticals sector perform RBC Capital Markets
20.04.11 Regeneron Pharmaceuticals overweight Barclays Capital
14.04.11 Regeneron Pharmaceuticals overweight Barclays Capital
17.03.11 Regeneron Pharmaceuticals overweight Barclays Capital
14.03.11 Regeneron Pharmaceuticals overweight Barclays Capital
02.03.11 Regeneron Pharmaceuticals overweight Barclays Capital
25.02.11 Regeneron Pharmaceuticals outperform RBC Capital Markets
23.02.11 Regeneron Pharmaceuticals hold Stifel, Nicolaus & Co., Inc.
15.02.11 Regeneron Pharmaceuticals overweight Barclays Capital